Cargando…
Mucormycosis and glucose‐regulated protein 78 in COVID‐19: Amenable to statin treatment?
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447360/ https://www.ncbi.nlm.nih.gov/pubmed/34133038 http://dx.doi.org/10.1111/joim.13347 |
_version_ | 1784569020612083712 |
---|---|
author | Vuorio, Alpo Kovanen, Petri T. |
author_facet | Vuorio, Alpo Kovanen, Petri T. |
author_sort | Vuorio, Alpo |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8447360 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84473602021-09-17 Mucormycosis and glucose‐regulated protein 78 in COVID‐19: Amenable to statin treatment? Vuorio, Alpo Kovanen, Petri T. J Intern Med Research Letters John Wiley and Sons Inc. 2021-08-03 2021-10 /pmc/articles/PMC8447360/ /pubmed/34133038 http://dx.doi.org/10.1111/joim.13347 Text en © 2021 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Research Letters Vuorio, Alpo Kovanen, Petri T. Mucormycosis and glucose‐regulated protein 78 in COVID‐19: Amenable to statin treatment? |
title | Mucormycosis and glucose‐regulated protein 78 in COVID‐19: Amenable to statin treatment? |
title_full | Mucormycosis and glucose‐regulated protein 78 in COVID‐19: Amenable to statin treatment? |
title_fullStr | Mucormycosis and glucose‐regulated protein 78 in COVID‐19: Amenable to statin treatment? |
title_full_unstemmed | Mucormycosis and glucose‐regulated protein 78 in COVID‐19: Amenable to statin treatment? |
title_short | Mucormycosis and glucose‐regulated protein 78 in COVID‐19: Amenable to statin treatment? |
title_sort | mucormycosis and glucose‐regulated protein 78 in covid‐19: amenable to statin treatment? |
topic | Research Letters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447360/ https://www.ncbi.nlm.nih.gov/pubmed/34133038 http://dx.doi.org/10.1111/joim.13347 |
work_keys_str_mv | AT vuorioalpo mucormycosisandglucoseregulatedprotein78incovid19amenabletostatintreatment AT kovanenpetrit mucormycosisandglucoseregulatedprotein78incovid19amenabletostatintreatment |